1. Home
  2. INDP vs GTN Comparison

INDP vs GTN Comparison

Compare INDP & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

SELL

Current Price

$3.07

Market Cap

438.4M

Sector

Health Care

ML Signal

SELL

GTN

Gray Television Inc.

HOLD

Current Price

$4.67

Market Cap

432.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
GTN
Founded
2000
1897
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
438.4M
432.5M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
INDP
GTN
Price
$3.07
$4.67
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
451.9K
★ 831.8K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
★ 6.93%
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,095,000,000.00
Revenue This Year
N/A
$17.38
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.92
$3.55
52 Week High
$5.96
$6.44

Technical Indicators

Market Signals
Indicator
INDP
GTN
Relative Strength Index (RSI) 55.54 53.85
Support Level $2.05 $4.47
Resistance Level $3.75 $4.70
Average True Range (ATR) 0.33 0.19
MACD 0.03 0.02
Stochastic Oscillator 78.48 64.66

Price Performance

Historical Comparison
INDP
GTN

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

Share on Social Networks: